Substituted aryl-indole compounds and their kynurenine/kynuramine-like metabolites as therapeutic agents
申请人:NEURIM PHARMACEUTICALS (1991) LIMITED
公开号:EP2664615A1
公开(公告)日:2013-11-20
This invention is directed to substituted aryl compounds, which are linked to a substituted indole moiety by various linkers, and the kynurenine/kynuramine-like metabolites of these agents, their preparation and pharmaceutical compositions containing these compounds. This invention further is directed to the pharmaceutical use of the compounds for inhibiting GSK3β kinase and/or modulating N-methyl-D-aspartate (NMDA) channel activities for the treatment of neurodegenerative and other disorders.
本发明涉及通过各种连接剂与取代的吲哚分子相连的取代芳基化合物,以及这些制剂的犬尿氨酸/犬尿氨酸样代谢物、其制备方法和含有这些化合物的药物组合物。本发明进一步涉及这些化合物的药物用途,用于抑制 GSK3β 激酶和/或调节 N-甲基-D-天冬氨酸(NMDA)通道活性,以治疗神经退行性疾病和其他疾病。